InsiderClue
Insiders · Profile

Kaye Edward M. MD

Director at Stoke Therapeutics · Director at CYTOKINETICS · Director at Sarepta Therapeutics. Filing since 27 Feb 2015. CIK 0001522780

STOK Stoke Therapeutics, Inc. Director · 22 trades CYTK CYTOKINETICS INC Director · 10 trades SRPT Sarepta Therapeutics, Inc. Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
STOK Stoke Therapeutics, Inc.
18 Aug 2026
Director
Sold at will
12,567
$402.53K
9.2%
CYTK CYTOKINETICS INC
1 Jun 2026
Director
Sold on a plan
2,933
$223.17K
22.2%
STOK Stoke Therapeutics, Inc.
8 Dec 2025
Director
Sold on a plan
13,430
$433.39K
21.5%
STOK Stoke Therapeutics, Inc.
5 Dec 2025
Director
Sold on a plan
8,548
$267.76K
12.0%
STOK Stoke Therapeutics, Inc.
4 Dec 2025
Director
Sold on a plan
6,453
$199.20K
8.3%
STOK Stoke Therapeutics, Inc.
3 Dec 2025
Director
Sold at will
1,070
$32.79K
2.0%
STOK Stoke Therapeutics, Inc.
2 Dec 2025
Director
Sold at will
1,066
$31.75K
2.0%
CYTK CYTOKINETICS INC
1 Dec 2025
Director
Sold on a plan
28,064
$1.87M
73.8%
CYTK CYTOKINETICS INC
11 Nov 2025
Director
Sold on a plan
5,175
$336.79K
34.2%
STOK Stoke Therapeutics, Inc.
8 Oct 2025
Director
Sold on a plan
25,000
$750.00K
33.7%
CYTK CYTOKINETICS INC
6 Oct 2025
Director
Sold on a plan
6,757
$405.42K
40.9%
STOK Stoke Therapeutics, Inc.
3 Oct 2025
Director
Sold on a plan
42,461
$1.07M
46.4%
CYTK CYTOKINETICS INC
30 Sep 2025
Director
Sold on a plan
6,695
$368.76K
28.8%
STOK Stoke Therapeutics, Inc.
3 Sep 2025
Director
Sold on a plan
45,996
$925.86K
33.4%
CYTK CYTOKINETICS INC
2 Sep 2025
Director
Sold on a plan
6,756
$337.80K
22.5%
STOK Stoke Therapeutics, Inc.
2 Sep 2025
Director
Sold on a plan
14,860
$299.26K
9.7%
STOK Stoke Therapeutics, Inc.
29 Aug 2025
Director
Sold on a plan
1,029
$20.58K
0.7%
STOK Stoke Therapeutics, Inc.
18 Aug 2025
Director
Sold at will
12,126
$221.15K
7.3%
CYTK CYTOKINETICS INC
5 Jun 2025
Director
Sold on a plan
3,636
$116.72K
10.9%
STOK Stoke Therapeutics, Inc.
19 Mar 2025
Director
Sold at will
8,907
$73.66K
6.0%
STOK Stoke Therapeutics, Inc.
18 Mar 2025
Director
Sold at will
10,382
$90.01K
6.5%
STOK Stoke Therapeutics, Inc.
9 Dec 2024
CEO
Sold at will
6,786
$88.16K
9.9%
STOK Stoke Therapeutics, Inc.
6 Dec 2024
CEO
Sold at will
6,170
$78.84K
8.2%
STOK Stoke Therapeutics, Inc.
20 May 2024
CEO
Sold on a plan
42,350
$653.53K
61.1%
STOK Stoke Therapeutics, Inc.
19 Mar 2024
CEO
Sold at will
11,150
$68.00K
13.9%
CYTK CYTOKINETICS INC
5 Aug 2022
Director
Sold, plan not stated
11,428
$571.40K
47.6%
CYTK CYTOKINETICS INC
23 Dec 2021
Director
Sold, plan not stated
15,000
$675.00K
68.9%
STOK Stoke Therapeutics, Inc.
18 Dec 2020
CEO
Sold, plan not stated
5,194
$311.64K
100%
STOK Stoke Therapeutics, Inc.
17 Dec 2020
CEO
Sold, plan not stated
19,806
$1.19M
79.2%
STOK Stoke Therapeutics, Inc.
27 Nov 2020
CEO
Sold, plan not stated
12,152
$607.60K
32.7%
STOK Stoke Therapeutics, Inc.
25 Nov 2020
CEO
Sold, plan not stated
12,848
$642.40K
25.7%
CYTK CYTOKINETICS INC
5 Oct 2020
Director
Sold, plan not stated
20,000
$600.00K
100%
SRPT Sarepta Therapeutics, Inc.
20 Jul 2017
Director
Sold, plan not stated
10,000
$410.00K
16.0%
SRPT Sarepta Therapeutics, Inc.
22 Sep 2016
President, CEO & CMO
Sold, plan not stated
40,179
$2.41M
34.3%
SRPT Sarepta Therapeutics, Inc.
19 Sep 2016
President, CEO & CMO
Sold, plan not stated
24,352
$1.22M
24.0%
SRPT Sarepta Therapeutics, Inc.
14 Sep 2016
SVP Interim CEO & CMO
Sold, plan not stated
24,557
$736.71K
24.2%
SRPT Sarepta Therapeutics, Inc.
27 Feb 2015
SVP & Chief Medical Officer
Bought
800
$9.45K
157%
37 decisions on file.